Judge Says UCL Claim In Stem Cell Case ‘Displaced’ By Trade Secrets Claim

Mealey's (February 22, 2022, 2:22 PM EST) -- SAN FRANCISCO — A California federal judge on Feb. 21 dismissed a U.S. stem cell company’s counterclaim for violation of California’s unfair competition law (UCL) in a pending suit against a Canadian company and its affiliates because it was “displaced” by the company’s sufficiently pleaded state law claim for misappropriation of trade secrets....